comparemela.com
Home
Live Updates
Bellus shareholders approve US$2-billion takeover by GSK; de
Bellus shareholders approve US$2-billion takeover by GSK; de
Bellus shareholders approve US$2-billion takeover by GSK; deal set to close this month
The US$14.75-a-share deal, which goes to the Quebec Superior Court next week for approval, is the latest in a series of US$1-billion-plus takeovers of Canadian life sciences companies
Related Keywords
Quebec ,
Canada ,
Vancouver ,
British Columbia ,
United Kingdom ,
Canadian ,
British ,
Christinne Muschi ,
Luke Miels ,
Roberto Bellini ,
Biochem Pharma ,
Francesco Bellini ,
Drug Administration ,
Bellus Health ,
Neurochem Inc ,
Quebec Superior Court ,
Baylis Medical Co ,
Biochem Pharma Inc ,
Shire Pharmaceuticals ,
Trillium Therapeutics Inc ,
Bellus Health Inc ,
Clementia Pharmaceuticals Inc ,
Chinook Therapeutics Inc ,
Log Increate Free ,
Trillium Therapeutics ,
Baylis Medical ,
Streetwise ,
Bellus ,
Inc ,
Drug ,
Gsk ,
Offer ,
Bellini ,
Stock ,
Laval ,
Novartis Ag ,